1. Home
  2. XNDU vs SUPN Comparison

XNDU vs SUPN Comparison

Compare XNDU & SUPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

XNDU

Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

N/A

Current Price

$10.77

Market Cap

3.2B

Sector

N/A

ML Signal

N/A

Logo Supernus Pharmaceuticals Inc.

SUPN

Supernus Pharmaceuticals Inc.

HOLD

Current Price

$44.52

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
XNDU
SUPN
Founded
2016
2005
Country
Canada
United States
Employees
264
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
2010

Fundamental Metrics

Financial Performance
Metric
XNDU
SUPN
Price
$10.77
$44.52
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
5
Target Price
$44.00
$61.60
AVG Volume (30 Days)
1.1M
677.5K
Earning Date
N/A
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$392,755,000.00
Revenue This Year
N/A
$22.70
Revenue Next Year
N/A
$19.14
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.97
$35.51
52 Week High
$42.44
$59.68

Technical Indicators

Market Signals
Indicator
XNDU
SUPN
Relative Strength Index (RSI) 47.06 39.38
Support Level $10.63 $43.43
Resistance Level $11.27 $46.79
Average True Range (ATR) 0.69 1.50
MACD 0.15 -0.32
Stochastic Oscillator 69.51 5.69

Price Performance

Historical Comparison
XNDU
SUPN

About XNDU Xanadu Quantum Technologies Limited Class B Subordinate Voting Shares

Xanadu Quantum Technologies Ltd specializes in designing photonic devices and the platforms around them, including the experimentation and development of quantum computers available on the cloud with supporting software, along with quantum simulators and other related products and offerings. Its products include: Aurora, PennyLane, Catalyst, Lightning, Catalyst and PennyLane Codebook. The company operates in industries such as automotive, aerospace, energy, materials, and semiconductor sectors.

About SUPN Supernus Pharmaceuticals Inc.

Supernus Pharmaceuticals Inc is a specialty pharmaceutical company. The company is engaged in developing and commercializing products for the treatment of central nervous system diseases, including neurological and psychiatric disorders. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson's Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The company's products include Trokendi XR, Oxtellar XR, Qelbree, APOKYN, XADAGO, MYOBLOC, GOCOVRI, Osmolex ER, and others.

Share on Social Networks: